Mass. Biotech Co. Liable For CEO Duping Investors, SEC Says

By Aaron Leibowitz · July 23, 2019, 7:11 PM EDT

A Massachusetts cancer diagnostics company whose founder was sentenced to 27 months in prison for squandering most of the $1.2 million he raised from investors should be held liable for his...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

United States Securities and Exchange Commission v. Muraca et al

Case Number

1:17-cv-11400

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

July 31, 2017